Search Results for: dana-farber boston children's
It’s personal: How the Boston Children’s progeria research community brought new life to an old drug
In late November, the U.S. Food and Drug Administration (FDA) approved a repurposed cancer drug called lonafarnib to treat Hutchinson-Gilford …Read More
Nurses Week 2021: Nurse-led contact tracing team helps reduce the spread of COVID-19
As COVID-19 evolved into a serious threat in March 2020, protecting the health of patients, families, and employees at Boston …Read More
New approach to gene therapy helps smooth road for people with sickle cell disease
Gene therapy has been transformative for individuals with sickle cell disease, a genetic condition caused by a mutation in the …Read More
Rh alloimmunization: A family’s experience across two pregnancies
After her second child was born 14 years ago, Erin was convinced she’d never have another baby. Not because of …Read More
Mapping ‘neighborhoods’ in aggressive childhood brain tumors
The third-most common kind of childhood brain tumor, supratentorial ependymoma, is an aggressive cancer that often returns after surgery and …Read More
A true hero’s journey: How a team approach helped Wolfie overcome pancreatitis
Wolfgang, affectionately known as “Wolfie,” is a bright and energetic 7-year-old with a quick wit and a love for making …Read More
Tough cookie: Steroid therapy helps Alessandra thrive with Diamond-Blackfan anemia
Two-year-old Alessandra is many things. She’s sweet, happy, curious, and, according to her parents, Ralph and Irma, a budding food …Read More
A new druggable cancer target: RNA-binding proteins on the cell surface
In 2021, research led by Ryan Flynn, MD, PhD, and his mentor, Nobel laureate Carolyn Bertozzi, PhD, opened a new …Read More
A small act of kindness: Blood donations get Sadie off the sidelines after her aplastic anemia diagnosis
In March of 2024, Sadie’s life was interrupted. A busy high school senior with classes to attend, soccer matches to …Read More
Could a pill treat sickle cell disease?
The new gene therapies for sickle cell disease — including the gene-editing treatment Casgevy, based on research at Boston Children’s …Read More